Co-Authors
This is a "connection" page, showing publications co-authored by Xavier Keutgen and Nicholas Feinberg.
Connection Strength
0.305
-
Surgery enhances the effectiveness of peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumors. Surgery. 2025 Jan; 177:108834.
Score: 0.244
-
MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy. Endocr Relat Cancer. 2024 Nov 01; 31(11).
Score: 0.061